RT @XMRV_GA: #AMAmtg Rituximab helps pts with #MECFS.Could it be an auto-immune disease?Pts need validation trials http://t.co/uNMcrwAF Sick 4 decades
@DrVes Rituximab helps pts with #MECFS.Could it be an auto-immune disease?Pts need validation trials http://t.co/uNMcrwAF Sick 4 decades
@DickKnox Rituximab helps pts with #MECFS.Could it be an auto-immune disease?Pts need validation trials http://t.co/uNMcrwAF Sick 4 decades
@DrLaPook Rituximab helps pts with #MECFS.Could it be an auto-immune disease?Pts need validation trials http://t.co/uNMcrwAF Sick 4 decades
@drmannyonFOX Rituximab helps pts with #MECFS.Could it be an auto-immune disease?Pts need validation trials http://t.co/uNMcrwAF
RT @XMRV_GA: #AMAmtg Rituximab helps pts with #MECFS.Could it be an auto-immune disease?Pts need validation trials http://t.co/uNMcrwAF Sick 4 decades
#AMAmtg Rituximab helps pts with #MECFS.Could it be an auto-immune disease?Pts need validation trials http://t.co/uNMcrwAF Sick 4 decades
@AmerMedicalAssn Rituximab helps pts with #MECFS.Could it be an auto-immune dis.? Pts need validation trials http://t.co/uNMcrwAF We r sick
@DrAnasYounes Rituximab helps pts with #MECFS.Could it be an auto-immune disease?Pts need validation trials http://t.co/uNMcrwAF Sick 30 yrs
@cochranecollab Rituximab helps pts with #MECFS.Could it be an auto-immune disease?Pts need validation trials http://t.co/uNMcrwAF
@BioMedCentral Rituximab helps pts with #MECFS.Could it be an auto-immune disease?Pts need validation trials http://t.co/uNMcrwAF Sick 30 yr
@uoftmedicine Rituximab helps pts with #MECFS.Could it be an auto-immune disease?Pts need validation trials http://t.co/uNMcrwAF
@CIHC_ca Rituximab helps pts with #MECFS.Could it be an auto-immune disease?Pts need validation trials http://t.co/uNMcrwAF Sick 4 decades
@IRSC_CIHR Rituximab helps pts with #MECFS.Could it be an auto-immune disease?Pts need validation trials http://t.co/uNMcrwAF Sick 4 decades
@healthcouncilca Rituximab helps pts with #MECFS.Could it be an auto-immune disease?Pts need validation trials http://t.co/uNMcrwAF
@researchimpact Rituximab helps pts with #MECFS.Could it be an auto-immune disease?Pts need validation trials http://t.co/uNMcrwAF
@NCDchat Rituximab helps pts with #MECFS.Could it be an auto-immune disease?Pts need validation trials http://t.co/uNMcrwAF Sick 4 decades
@guardianscience Rituximab helps pts with #MECFS.Could it be an auto-immune disease?Pts need validation trials http://t.co/uNMcrwAF
@EvidenceBsdMed Rituximab helps pts with #MECFS.Could it b an auto-immune disease?Pts need validation trials http://t.co/uNMcrwAF Pls help
@amednews Rituximab helps pts with #MECFS.Could it be an auto-immune disease?Pts need validation trials http://t.co/uNMcrwAF Sick 4 decades
#PLoS: Benefit from B-Lymphocyte Depletion Using the Anti-CD20 Antibody Rituximab in Chro... http://t.co/koo7Lnsw #ME #ME/CVS
414,000 #MECFS patients in Canada need larger drug trials for Rituximab http://t.co/H0C2bDQH #cdnpoli
RT @XMRV_GA: Since #mecfs patients respond rather well to Rituximab,does it make it an auto-immune disease #APR2011 http://t.co/uNMcrwAF
Since #mecfs patients respond rather well to Rituximab,does it make it an auto-immune disease #APR2011 http://t.co/uNMcrwAF
RT @Milo_Paradiso: #ACR2011 Pts with #MECFS have been left behind by medicine for decades, and now this: http://t.co/9vQT8ZNM #rheum will you help us now?
RT @Milo_Paradiso: #ACR2011 Pts with #MECFS have been left behind by medicine for decades, and now this: http://t.co/9vQT8ZNM #rheum will you help us now?
@nhsdirect Good morning to you! Patients with #MECFS need you to fund validation clinical trial with Rituximab http://t.co/uNMcrwAF no less
@FAQMP @bobraeMP Will the Liberals support clinical trials for Rituximab in 414k #MECFS patients in Canada?http://t.co/H0C2bDQH #cdnpoli”
414,000 #MECFS patients in Canada need larger drug trials for Rituximab http://t.co/H0C2bDQH #cdnpoli”
RT @CFSResearch: Rituximab in Chronic Fatigue Syndrome Study Link http://t.co/oBMKRBsu
@EvidenceNetwork 413 000 pts with MECFS in Canada & no #healthcare. Left behind for 25 years & now this http://t.co/uNMcrwAF Will you help?
RT @XMRV_GA: @westr http://t.co/DLnqRYYN The Norwegian government, where this paper originates apologized to their pts with #MECFS 4 lack of treatment
Recent Publication: Benefit from B-Lymphocyte Depletion Using the Anti-CD20 Antibody Rituximab in Chronic Fatigu... http://t.co/7T1NKH4K
@esmultivac Otra somanta para ti http://t.co/J4o8xsSh http://t.co/krlg7a0F http://t.co/vTxOiYZ5 rectifica y pide disculpas a los enfermos.
RT @DeBortgjemte: Norwegian study on Rituximab in ME/CFS most viewed on PLoS ONE, more than 16.000 views. http://t.co/0b5Fuko8 #ME #cfs
Fluge: Norwegian national initiative: randomized, blinded Phase III study; RTX in #ME #CFS after http://t.co/nATO7PbV http://t.co/Sq67CR59
Another example of patient experiences influencing direction of future research http://t.co/cFC5TXKF
RT @DeBortgjemte: Norwegian study on Rituximab in ME/CFS most viewed on PLoS ONE, more than 16.000 views. http://t.co/0b5Fuko8 #ME #cfs
Haukeland-studien på kreftmedisin mot ME/CFS er mest sette artikkelen på PLoS ONE:over 16.000 visninger. http://t.co/0b5Fuko8 #Bortgjemt #ME
Norwegian study on Rituximab in ME/CFS most viewed on PLoS ONE, more than 16.000 views. http://t.co/0b5Fuko8 #ME #cfs
RT @BioWorld: Small study, but double-blind and placebo-controlled: Rituxan treats chronic fatigue syndrome. Is CFS autoimmune? http://t.co/p0D4MMgm
RT @BioWorld: Small study, but double-blind and placebo-controlled: Rituxan treats chronic fatigue syndrome. Is CFS autoimmune? http://t.co/p0D4MMgm
RT @BioWorld: Small study, but double-blind and placebo-controlled: Rituxan treats chronic fatigue syndrome. Is CFS autoimmune? http://t.co/p0D4MMgm
RT @BioWorld: Small study, but double-blind and placebo-controlled: Rituxan treats chronic fatigue syndrome. Is CFS autoimmune? http://t.co/p0D4MMgm
RT @BioWorld: Small study, but double-blind and placebo-controlled: Rituxan treats chronic fatigue syndrome. Is CFS autoimmune? http://t.co/p0D4MMgm
Rituximab results impact future direction of biomedical research for CFS http://t.co/pl8KsKgi #innovation
RT @BioWorld: Small study, but double-blind and placebo-controlled: Rituxan treats chronic fatigue syndrome. Is CFS autoimmune? http://t.co/p0D4MMgm
RT @BioWorld: Small study, but double-blind and placebo-controlled: Rituxan treats chronic fatigue syndrome. Is CFS autoimmune? http://t.co/p0D4MMgm
RT @BioWorld: Small study, but double-blind and placebo-controlled: Rituxan treats chronic fatigue syndrome. Is CFS autoimmune? http://t.co/p0D4MMgm
414,000 #MECFS patients in Canada need larger drug trials for Rituximab http://t.co/H0C2bDQH #cdnpoli”
RT @BioWorld: Small study, but double-blind and placebo-controlled: Rituxan treats chronic fatigue syndrome. Is CFS autoimmune? http://t.co/p0D4MMgm
@westr http://t.co/DLnqRYYN The Norwegian government, where this paper originates apologized to their pts with #MECFS 4 lack of treatment
Benefit from B-Lymphocyte Depletion Using the Anti-CD20 Antibody ... http://t.co/cloBNyuv
RT @ME_forME: For who's interested: Here's the original study on Rituximab in ME/CFS that shows major improvement in 67% of pts http://t.co/ybkOSkvg #CFS
RT @XMRV_GA: “@Killandra: @strombo 330,000 #MECFS patients in Canada need larger drug trials for Rituximab http://t.co/uNMcrwAF #cdnpoli” we are 414K now
RT @Killandra: @spaikin 330,000 #MECFS patients in Canada need larger drug trials for Rituximab http://t.co/H0C2bDQH #cdnpoli
RT @Killandra: 330,000 #MECFS patients in Canada need larger drug trials for Rituximab http://t.co/H0C2bDQH #cdnpoli
“@Killandra: @strombo 330,000 #MECFS patients in Canada need larger drug trials for Rituximab http://t.co/uNMcrwAF #cdnpoli” we are 414K now
@strombo 330,000 #MECFS patients in Canada need larger drug trials for Rituximab http://t.co/H0C2bDQH #cdnpoli
330,000 #MECFS patients in Canada need larger drug trials for Rituximab http://t.co/H0C2bDQH #cdnpoli
@spaikin 330,000 #MECFS patients in Canada need larger drug trials for Rituximab http://t.co/H0C2bDQH #cdnpoli
@evansolomoncbc @CBCTheHouse http://t.co/H0C2bDQH #MECFS patients need larger clinical trials of Rituximab #cdnpoli
@Carolyn_Bennett http://t.co/H0C2bDQH ME/CFS patients need larger clinical trials of Rituximab #cdnpoli
RT @BioWorld: Small study, but double-blind and placebo-controlled: Rituxan treats chronic fatigue syndrome. Is CFS autoimmune? http://t.co/p0D4MMgm
RT @BioWorld: Small study, but double-blind and placebo-controlled: Rituxan treats chronic fatigue syndrome. Is CFS autoimmune? http://t.co/p0D4MMgm
For who's interested: Here's the original study on Rituximab in ME/CFS that shows major improvement in 67% of pts http://t.co/ybkOSkvg #CFS
Did you know someone with ME/CFS could undergo chemotherapy and actually feel better (not worse)? http://t.co/3uk2Jeoh #spoonie #mecfs
Important study! Hope more follow soon. “@BoraZ: Is Chronic Fatigue Syndrome an auto-immune disease? http://t.co/zW7trYxy”
Is Chronic Fatigue Syndrome an auto-immune disease? http://t.co/QYqgZ16n
Benefit from Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome. via @PLoS http://t.co/5Ak021xk #pm101 #CFS #rheum #autoimmune
I would love to have known about this 25 years ago when struck with #MECFS http://t.co/8VfmMVxA
RT @trished: “@BMJ_BestHealth #CFS small, intriguing short-term study http://t.co/WpXIKpbZ” <- potentially toxic drug & -ve result for primary outcome
RT @me_positive: http://t.co/Ac7aILoD Benefit B-Lymphocyte Depletion Using the Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome. #MEforMEawareness
http://t.co/Ac7aILoD Benefit B-Lymphocyte Depletion Using the Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome. #MEforMEawareness
RT @trished: “@BMJ_BestHealth #CFS small, intriguing short-term study http://t.co/WpXIKpbZ” <- potentially toxic drug & -ve result for primary outcome
“@BMJ_BestHealth #CFS small, intriguing short-term study http://t.co/WpXIKpbZ” <- potentially toxic drug & -ve result for primary outcome
Could this be a breakthrough? http://t.co/yEuXFULI
@DrChrisSteele Have you seen this promising research re ME/CFS? http://t.co/uNEL1UFp
Benefit from B-Lymphocyte Depletion Using the Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome #mAbs #CFS http://t.co/LjltImEg
RT @ME_forME: Here's the study on Rituximab/Rituxan in ME/CFS that shows major improvement in 67 % of patients http://t.co/ybkOSkvg #mecfs #ME_ICC
Here's the study on Rituximab/Rituxan in ME/CFS that shows major improvement in 67 % of patients http://t.co/ybkOSkvg #mecfs #ME_ICC
@medicalstudents http://t.co/UTo2cGGd Cancer drug Rituximab: a breakthrough treatment for the neuro-immune disease ME
@MDLinx http://t.co/UTo2cGGd Cancer drug Rituximab: a breakthrough treatment for the neuro-immune disease ME
RT @XMRV_GA: #acr2011 For 3 decades now, pts were told #MECFS was in their head http://t.co/uNMcrwAF #rheum will you help us now?Rituximab is our chance
PLoS ONE: Benefit from B-Lymphocyte Depletion Using the Anti <b>...</b>: Chronic fatigue… http://t.co/np9XNZSI
B-Lymphocyte Depletion with Rituximab #CFS #ME. A Double-Blind and Placebo-Controlled Study http://t.co/XTR7sJOZ <- When can I get mine?
RT @drvicmax: PLoS ONE: Benefit from B-Lymphocyte Depletion Using the Anti ...: Chronic fatigue syndrome (CFS) is a disease of... http://t.co/ujDPZPDf
PLoS ONE: Benefit from B-Lymphocyte Depletion Using the Anti ...: Chronic fatigue syndrome (CFS) is a disease of... http://t.co/ujDPZPDf
http://t.co/mwjV479C. ME /CFS Drug tried info #sjogrens
#acr2011 For 3 decades now, pts were told #MECFS was in their head http://t.co/uNMcrwAF #rheum will you help us now?Rituximab is our chance
RT @XMRV_GA: #ACR2011 Patients with #MECFS need larger clinical trials with Rituximab http://t.co/uNMcrwAF this is very strong evidence 4 illness plshelp
@ArthritisCanada Patients with #MECFS need larger clinical trials with Rituximab http://t.co/uNMcrwAF this is very strong evidence 4 illness
@HarvardHealth Patients with #MECFS need larger clinical trials with Rituximab http://t.co/uNMcrwAF this is very strong evidence 4 illness
@doctorakerkar Patients with #MECFS need larger clinical trials with Rituximab http://t.co/uNMcrwAF this is very strong evidence 4 illness
@ArthritisRUK Patients with #MECFS need larger clinical trials with Rituximab http://t.co/uNMcrwAF this is very strong evidence 4 illness
@SOCIETEARTHRITE Patients with #MECFS need larger clinical trials with Rituximab http://t.co/uNMcrwAF this is very strong evidence 4 illness
@sanjayguptaCNN Patients with #MECFS need larger clinical trials with Rituximab http://t.co/uNMcrwAF this is very strong evidence 4 illness
@ORGENTEC Patients with #MECFS need larger clinical trials with Rituximab http://t.co/uNMcrwAF this is very strong evidence 4 illness
@Arthritis_ARC Patients with #MECFS need larger clinical trials with Rituximab http://t.co/uNMcrwAF this is very strong evidence 4 illness
@Rheumatologe Patients with #MECFS need larger clinical trials with Rituximab http://t.co/uNMcrwAF this is very strong evidence 4 illness